{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T17:27:21Z","timestamp":1758216441981,"version":"3.44.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00520-025-09842-7","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T11:20:20Z","timestamp":1755775220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Iron-deficiency anemia evaluation and treatment in hospitalized cancer patients: a feasibility study"],"prefix":"10.1007","volume":"33","author":[{"given":"Michel","family":"Meyers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Paesmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolff","family":"Fleur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Libert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Kl\u00e1\u0161tersk\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"issue":"4","key":"9842_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1053\/j.seminhematol.2015.07.006","volume":"52","author":"MD Cappellini","year":"2015","unstructured":"Cappellini MD, Motta I (2015) Anemia in clinical practice\u2014definition and classification: does hemoglobin change with aging? Semin Hematol 52(4):261\u2013269","journal-title":"Semin Hematol"},{"issue":"Suppl 7A","key":"9842_CR2","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.1016\/j.amjmed.2003.12.008","volume":"116","author":"K Knight","year":"2004","unstructured":"Knight K, Wade S, Balducci L (2004) Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med 116(Suppl 7A):11S-26S","journal-title":"Am J Med"},{"issue":"15","key":"9842_CR3","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.ejca.2004.06.019","volume":"40","author":"H Ludwig","year":"2004","unstructured":"Ludwig H, Van Belle S, Barrett-Lee P et al (2004) The European Cancer Anemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anemia in cancer patients. Eur J Cancer 40(15):2293\u20132306","journal-title":"Eur J Cancer"},{"issue":"2","key":"9842_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jamda.2006.12.025","volume":"8","author":"DR Thomas","year":"2007","unstructured":"Thomas DR (2007) Anemia: it\u2019s all about quality of life. J Am Med Dir Assoc 8(2):80\u201382","journal-title":"J Am Med Dir Assoc"},{"issue":"Suppl 2","key":"9842_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1634\/theoncologist.5-suppl_2-19","volume":"5","author":"P Sabbatini","year":"2000","unstructured":"Sabbatini P (2000) The relationship between anemia and quality of life in cancer patients. Oncologist 5(Suppl 2):19\u201323","journal-title":"Oncologist"},{"issue":"6","key":"9842_CR6","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/annonc\/mdh235","volume":"15","author":"D Cella","year":"2004","unstructured":"Cella D, Kallich J, McDermott A, Xu X (2004) The longitudinal relationship of hemoglobin, fatigue, and quality of life in anemic cancer patients: results from five randomized clinical trials. Ann Oncol 15(6):979\u2013986","journal-title":"Ann Oncol"},{"issue":"2","key":"9842_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00277-017-3155-y","volume":"97","author":"N Visweshwar","year":"2018","unstructured":"Visweshwar N, Jaglal M, Sokol L, Zuckerman K (2018) Chemotherapy-related anemia. Ann Hematol 97(2):375\u2013376","journal-title":"Ann Hematol"},{"issue":"2","key":"9842_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/ajh.23628","volume":"89","author":"JA Gilreath","year":"2014","unstructured":"Gilreath JA, Stenehjem DD, Rodgers GM (2014) Diagnosis and treatment of cancer-related anemia. Am J Hematol 89(2):203\u2013212","journal-title":"Am J Hematol"},{"issue":"4","key":"9842_CR9","first-page":"1639","volume":"28","author":"A Saint","year":"2020","unstructured":"Saint A, Viotti J, Borchiellini D et al (2020) Iron deficiency during first-line chemotherapy in metastatic cancers: a prospective epidemiological study. Support Care Cancer 28(4):1639\u20131647","journal-title":"Support Care Cancer"},{"issue":"21","key":"9842_CR10","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1182\/blood-2016-11-709865","volume":"129","author":"TS Jokiranta","year":"2017","unstructured":"Jokiranta TS (2017) HUS and atypical HUS. Blood 129(21):2847\u20132856","journal-title":"Blood"},{"issue":"7","key":"9842_CR11","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1182\/blood.V80.7.1639.1639","volume":"80","author":"RT Means Jr","year":"1992","unstructured":"Means RT Jr, Krantz SB (1992) Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80(7):1639\u20131647","journal-title":"Blood"},{"issue":"19","key":"9842_CR12","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1182\/blood.2021013472","volume":"140","author":"O Marques","year":"2022","unstructured":"Marques O, Weiss G, Muckenthaler MU (2022) The role of iron in chronic inflammatory diseases: from mechanisms to treatment options in anemia of inflammation. Blood 140(19):2011\u20132023","journal-title":"Blood"},{"issue":"7","key":"9842_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1182\/blood.2019004017","volume":"136","author":"JA Gilreath","year":"2020","unstructured":"Gilreath JA, Rodgers GM (2020) How i treat cancer-associated anemia. Blood 136(7):801\u2013813","journal-title":"Blood"},{"issue":"1","key":"9842_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","volume":"133","author":"G Weiss","year":"2019","unstructured":"Weiss G, Ganz T, Goodnough LT (2019) Anemia of inflammation. Blood 133(1):40\u201350","journal-title":"Blood"},{"issue":"1","key":"9842_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/clinchem\/44.1.45","volume":"44","author":"AE Mast","year":"1998","unstructured":"Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG (1998) Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem 44(1):45\u201351","journal-title":"Clin Chem"},{"issue":"8","key":"9842_CR16","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1093\/annonc\/mds112","volume":"23","author":"M Aapro","year":"2012","unstructured":"Aapro M, Osterborg A, Gascon P, Ludwig H, Beguin Y (2012) Prevalence and management of cancer-related anemia, iron deficiency, and the specific role of intravenous iron. Ann Oncol 23(8):1954\u20131962","journal-title":"Ann Oncol"},{"issue":"7","key":"9842_CR17","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1093\/annonc\/mdt118","volume":"24","author":"H Ludwig","year":"2013","unstructured":"Ludwig H, Muldur E, Endler G, Hubl W (2013) Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status, and anemia. Ann Oncol 24(7):1886\u20131892","journal-title":"Ann Oncol"},{"issue":"9","key":"9842_CR18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s12094-013-1155-5","volume":"16","author":"J Castro","year":"2014","unstructured":"Castro J, Gasc\u00f3n P, Casas A, Mu\u00f1oz-Langa J, Alberola V, Cucala M et al (2014) Iron deficiency in patients with solid tumours: prevalence and management in clinical practice. Clin Transl Oncol sept 16(9):823\u2013828","journal-title":"Clin Transl Oncol sept"},{"issue":"12","key":"9842_CR19","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1182\/blood-2011-04-346304","volume":"118","author":"PA Krayenbuehl","year":"2011","unstructured":"Krayenbuehl PA, Battegay E, Breymann C et al (2011) Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood 118(12):3222\u20133227","journal-title":"Blood"},{"key":"9842_CR20","doi-asserted-by":"publisher","first-page":"f4822","DOI":"10.1136\/bmj.f4822","volume":"347","author":"E Litton","year":"2013","unstructured":"Litton E, Xiao J, Ho KM (2013) Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ 347:f4822","journal-title":"BMJ"},{"issue":"7","key":"9842_CR21","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1200\/JCO.2004.08.119","volume":"22","author":"M Auerbach","year":"2004","unstructured":"Auerbach M, Ballard H, Trout JR, McIlwain M, Ackerman A, Bahrain H et al (2004) Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial. J Clin Oncol 22(7):1301\u20131307","journal-title":"J Clin Oncol"},{"issue":"1","key":"9842_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mayocp.2014.10.007","volume":"90","author":"T Avni","year":"2015","unstructured":"Avni T, Bieber A, Grossman A et al (2015) The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc 90(1):12\u201323","journal-title":"Mayo Clin Proc"},{"issue":"14","key":"9842_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11144156","volume":"11","author":"S Buchrits","year":"2022","unstructured":"Buchrits S, Itzhaki O, Avni T et al (2022) Intravenous iron supplementation for the treatment of chemotherapy-induced anemia: a systematic review and meta-analysis of randomized controlled trials. J Clin Med 11(14):4156","journal-title":"J Clin Med"},{"issue":"Suppl 4","key":"9842_CR24","doi-asserted-by":"publisher","first-page":"iv96","DOI":"10.1093\/annonc\/mdx758","volume":"29","author":"M Aapro","year":"2018","unstructured":"Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gasc\u00f3n P, Glaspy J et al (2018) Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 29(Suppl 4):iv96-110","journal-title":"Ann Oncol."},{"issue":"Suppl 3","key":"9842_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1634\/theoncologist.13-S3-33","volume":"13","author":"MS Aapro","year":"2008","unstructured":"Aapro MS, Link H (2008) September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents. Oncologist 13(Suppl 3):33\u201336","journal-title":"Oncologist"},{"issue":"15","key":"9842_CR26","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1200\/JCO.18.02142","volume":"37","author":"J Bohlius","year":"2019","unstructured":"Bohlius J, Bohlke K, Castelli R et al (2019) Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO\/ASH clinical practice guideline update. J Clin Oncol 37(15):1336\u20131351","journal-title":"J Clin Oncol"},{"issue":"9","key":"9842_CR27","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","volume":"1823","author":"T Ganz","year":"2012","unstructured":"Ganz T, Nemeth E (2012) Hepcidin and iron homeostasis. Biochimica et Biophysica Acta (BBA) 1823(9):1434\u20131443","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"5","key":"9842_CR28","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/bjh.12311","volume":"161","author":"DW Thomas","year":"2013","unstructured":"Thomas DW, Hinchliffe RF, Briggs C, Macdougall IC, Littlewood T, Cavill I (2013) Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol 161(5):639\u2013648","journal-title":"Br J Haematol"},{"issue":"1","key":"9842_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1182\/hematology.2019000059","volume":"2019","author":"C Camaschella","year":"2019","unstructured":"Camaschella C (2019) Management of iron deficiency. Hematol Am Soc Hematol Educ Program 2019(1):315\u2013322. https:\/\/doi.org\/10.1182\/hematology.2019000059","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"1","key":"9842_CR30","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1182\/hematology.2020000136","volume":"2020","author":"MD Cappellini","year":"2020","unstructured":"Cappellini MD, Comin-Colet J, de Francisco A, Dignass A, Doehner W, Lam CSP et al (2020) Diagnosis and management of iron deficiency in patients with heart failure: a practical clinical consensus statement. Hematology Am Soc Hematol Educ Program 2020(1):478\u2013486. https:\/\/doi.org\/10.1182\/hematology.2020000136","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"9842_CR31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/CCO.0000000000001024","volume":"36","author":"M Meyers","year":"2024","unstructured":"Meyers M, Salmon M, Libert I, Kl\u00e1\u0161tersk\u00fd J (2024) A meta-analysis on the risk of infection associated with intravenous iron therapy in cancer-associated anaemia: a double-edged sword? Current Opin Oncology juill 36(4):223","journal-title":"Current Opin Oncology juill"},{"issue":"3","key":"9842_CR32","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1515\/cclm-2017-0823","volume":"56","author":"F Wolff","year":"2018","unstructured":"Wolff F (2018) Iron metabolism: from basic biology to clinical laboratory aspects. Clin Chem Lab Med 56(3):310\u2013325. https:\/\/doi.org\/10.1515\/cclm-2017-0823","journal-title":"Clin Chem Lab Med"},{"issue":"21","key":"9842_CR33","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.1182\/blood-2008-12-195651","volume":"113","author":"I Theurl","year":"2009","unstructured":"Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A et al (2009) Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood. 113(21):5277\u201386","journal-title":"Blood."},{"issue":"2","key":"9842_CR34","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1111\/ajco.12762","volume":"14","author":"V Noronha","year":"2018","unstructured":"Noronha V, Joshi A, Patil VM, Banavali SD, Gupta S, Parikh PM et al (2018) Phase III randomized trial comparing intravenous to oral iron in patients with cancer-related iron deficiency anemia not on erythropoiesis stimulating agents. Asia Pac J Clin Oncol 14(2):e129\u2013e137","journal-title":"Asia Pac J Clin Oncol"},{"key":"9842_CR35","doi-asserted-by":"publisher","first-page":"e1003091","DOI":"10.1371\/journal.pmed.1003091","volume":"17","author":"J Jang","year":"2020","unstructured":"Jang J, Kim Y, Park S, Kim K, Kim W, Jung C et al (2020) Efficacy of intravenous iron treatment for chemotherapy-induced anemia: a prospective Phase II pilot clinical trial in South Korea. PLOS Med 17:e1003091","journal-title":"PLOS Med"},{"issue":"Supplement_1","key":"9842_CR36","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1182\/blood-2019-132135","volume":"134","author":"JA Gilreath","year":"2019","unstructured":"Gilreath JA, Makharadze T, Boccia RV, Krupa A, Henry DH (2019) Efficacy and safety of ferric carboxymaltose injection in reducing anemia in patients receiving chemotherapy for non-myeloid malignancies: a phase 3, placebo-controlled study (IRON CLAD). Blood. 134(Supplement_1):3535","journal-title":"Blood."},{"issue":"12","key":"9842_CR37","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s12032-014-0302-3","volume":"31","author":"M Hedenus","year":"2014","unstructured":"Hedenus M, Karlsson T, Ludwig H, Rzychon B, Felder M, Roubert B et al (2014) Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy. Med Oncol 31(12):302","journal-title":"Med Oncol"},{"issue":"23","key":"9842_CR38","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1182\/blood-2015-03-636407","volume":"125","author":"DP Steensma","year":"2015","unstructured":"Steensma DP, Sasu BJ, Sloan JA, Tomita DK, Loprinzi CL (2015) Serum hepcidin levels predict response to intravenous iron and darbepoetin in chemotherapy-associated anemia. Blood 125(23):3669\u20133671","journal-title":"Blood"},{"issue":"9","key":"9842_CR39","first-page":"1636","volume":"43","author":"G Weiss","year":"1997","unstructured":"Weiss G, Houston T, Kastner S, Johrer K, Gruber G, Tichelli A et al (1997) Soluble transferrin receptor in iron deficiency, anemia of chronic disease, and mixed-type anemia: the effects of iron supplementation. Clin Chem 43(9):1636\u20131638","journal-title":"Clin Chem"},{"issue":"1","key":"9842_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12185-017-2373-3","volume":"107","author":"D Girelli","year":"2018","unstructured":"Girelli D, Ugolini S, Busti F, Marchi G, Castagna A (2018) Modern iron replacement therapy: clinical and pathophysiological insights. Int J Hematol 107(1):16\u201330","journal-title":"Int J Hematol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09842-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09842-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09842-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T02:57:42Z","timestamp":1758164262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09842-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["9842"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09842-7","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All study procedures were approved by the \u201cEthics Committee of the Jules Bordet Institut\u201d (B079201730757). Clinical trial number: not applicable. We conducted the study in strict accordance with the ethical guidelines outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Participants in the study signed an informed consent after reading an information letter.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The signed consent documents included a sentence stating that the coded data may be used for the following purposes [\u2026] to publish the anonymized results of the study in scientific articles [\u2026].","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"804"}}